Abu Dhabi imposes a third dose for recipients of Sinopharm..and a Bahraini study: less effective than Western vaccines


The Emirate of Abu Dhabi, the capital of the United Arab Emirates, has announced that individuals who have received the Chinese Sinopharma vaccine must receive a third booster dose so that their condition remains green in the government’s “Al-Hosn” application.

The Abu Dhabi Media Office said in a tweet on Twitter that “individuals who received the second dose of the Sinopharma vaccine more than six months ago must receive the boosting dose to enhance their immunity and adhere to the protocol approved for each vaccine.”

The Emirati capital’s media office added that “there is a grace period that lasts until September 20, 2021, so that these restaurants can obtain the supporting dose and maintain the green status in the Al-Hosn application,” adding that “after September 20, they will not be allowed to enter public places limited to restaurants.” completely.”

Abu Dhabi requires that the status of the application of the fort be green to allow entry to most public places, including shopping centers, stadiums, etc., as the recipient of the full vaccination must perform a PCR examination every 30 days to keep the status green.

In a related context, a study was published in Bahrain that the deaths of corona for the full vaccinated were greater for those who received the Sinopharm vaccine compared to the rest of the western vaccines produced in Europe and the United States.

The study, conducted by the National Team to Combat the Corona Virus, in cooperation with researchers from Columbia University, showed that the death rate directly related to Covid-19 disease for people who received the full vaccine was greater for the recipients of the Sinopharm vaccination and was 046. percent, compared to 0.15 percent for the Pfizer-Biontech vaccine and 0. .03 percent for AstraZeneca.

The study concluded that 88 percent of Corona deaths in Bahrain were from those who had never received the anti-Coronavirus vaccination.

The study, which ran from December 2020 to July 2021, did not indicate the ages of the deceased or if they had other medical conditions.

Dr. Jalila Al-Sayed Jawad, one of the study’s authors, said that the results indicate that there is a difference in favor of the American vaccine, Pfizer, in the number of fully vaccinated cases that required hospitalization or stay in intensive care, compared to those who received Sinopharm.

Jawad, who is the head of the immunization group at the Bahraini Ministry of Health, said in statements to the newspaper:The Wall Street JournalThe results still need more in-depth studies.

And the study stated that 11.4 percent of the deaths of corona for vaccinated people were from those who received the Sinofarm vaccination, by 112 people, while the number of Covid-19 deaths from those who received the Pfizer vaccine was only 3 people, and the same number for those who received the “Sputnik V” vaccine, and one person obtained on CoviShield, an Indian-made version of AstraZeneca.

During the same period, 569,054 people in Bahrain received the Sinopharm vaccine, compared to 184,526 for Sputnik, 169,058 for Pfizer, and 73,765 for AstraZeneca.

Last June, the UAE and Bahrain introduced the Pfizer-Biontech vaccine to prevent the emerging corona virus, as a support dose for those who have already received the Chinese company Sinopharma’s vaccine, according to Reuters.

The UAE and Bahrain are among the first countries to use the Chinese Sinopharma vaccine, including the third phase of clinical trials last year.

And last December, Abu Dhabi confirmed that the preliminary results of the trials of the Sinopharm vaccine showed its effectiveness of 86 percent.

newspaper said “The Wall Street Journal“Chinese vaccines have become a major tool of Beijing’s international diplomacy, especially in developing countries that are unable to secure sufficient doses of American and European vaccines.


Please enter your comment!
Please enter your name here